We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current T5O market cap is 2.57M. The company's latest EPS is EUR -0.1616 and P/E is -3.16.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3k | 37k | 40k | 52k | 12k |
| Operating Income | -1.22M | -1.18M | -1.84M | -1.53M | -823k |
| Net Income | -1.42M | -1.28M | -1.84M | -4.06M | -830k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 16.37M | 17.86M | 22.3M | 18.27M | 21.61M |
| Total Liabilities | 2.87M | 110k | 370k | 400k | 190k |
| Total Equity | 13.51M | 17.75M | 21.93M | 17.87M | 21.42M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -1.26M | -911k | -1.66M | N/A | N/A |
| Investing | -3.3M | -2.43M | -4.8M | N/A | N/A |
| Financing | 5.19M | 2.66M | 6.02M | N/A | N/A |
| Market Cap | 2.57M |
| Price to Earnings Ratio | -3.16 |
| Price to Sales Ratio | 221.74 |
| Price to Cash Ratio | 1.42 |
| Price to Book Ratio | 0.12 |
| Dividend Yield | - |
| Shares Outstanding | 5.14M |
| Average Volume (1 week) | 1.5k |
| Average Volume (1 Month) | 1.95k |
| 52 Week Change | -74.36% |
| 52 Week High | 2.34 |
| 52 Week Low | 0.232 |
| Spread (Intraday) | 0.18 (30.76%) |
| Company Name | bioXXmed AG |
| Address |
riedstrasse 2 darmstadt 64295 |
| Website | https://bioxxmed.ag |
| Industry | investors, nec (6799) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
